Prothena targets rare protein-misfolding disease in late-stage study
December 02, 2014 at 17:40 PM EST
Elan Corp. spinout Prothena Corp. will take an experimental drug aimed at a rare protein-misfolding disease into a late-stage clinical trial, the company said Tuesday...